An Exploratory Study to Evaluate The Efficacy And Safety of HLX10, A Humanized Monoclonal Antibody Targeting Programmed Death-1 (PD-1) Protein In Chronic Hepatitis B Patients
Latest Information Update: 06 Oct 2022
At a glance
- Drugs Serplulimab (Primary) ; Entecavir; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Henlix Biotech
- 22 Apr 2020 Planned End Date changed from 30 Apr 2022 to 30 Jul 2022.
- 22 Apr 2020 Status changed from not yet recruiting to recruiting.
- 18 Nov 2019 Planned initiation date changed from 1 Nov 2019 to 1 Nov 2020.